Yearly infusion of zoledronic acid helps prevent fractures in postmenopausal women with osteoporosisBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39234.488356.DE (Published 05 July 2007) Cite this as: BMJ 2007;335:36
Research question Is once yearly intravenous zoledronic acid an effective treatment for postmenopausal osteoporosis?
Answer Yes. Yearly treatment prevents fractures and increases bone mineral density compared with a placebo.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial